Estamos no ar no ! Saiba mais
CDAK

Codiak BioSciences

Deslistada

CDAK foi retirado da bolsa em 4 de abril de 2023.

 

Sobre: Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.

Funcionários: 53

Notícias

Positiva
Neutra
Negativa
Sentimento 3 meses
Positiva 0%
Neutra 0%
Negativa 0%

Não recebemos notícias recentes sobre CDAK

Gráficos de preços implementados com Lightweight Charts™